Gosuranemab Uses, Dosage, Side Effects and more
Gosuranemab is under investigation in clinical trial NCT02460094 (Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy).
| Trade Name | Gosuranemab |
| Generic | Gosuranemab |
| Gosuranemab Other Names | BMS-986168, Gosuranemab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
